MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 82 filers reported holding MARINUS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $14,904,000 | +41.5% | 5,867,856 | +13.1% | 0.00% | 0.0% |
| Q1 2020 | $10,531,000 | +33.5% | 5,187,826 | +42.1% | 0.00% | – |
| Q4 2019 | $7,887,000 | +45.5% | 3,650,951 | +3.7% | 0.00% | – |
| Q3 2019 | $5,420,000 | -61.9% | 3,519,801 | +2.7% | 0.00% | -100.0% |
| Q2 2019 | $14,226,000 | +6.4% | 3,427,739 | +7.2% | 0.00% | 0.0% |
| Q1 2019 | $13,368,000 | +91.1% | 3,197,928 | +31.2% | 0.00% | – |
| Q4 2018 | $6,997,000 | -76.0% | 2,438,101 | -16.2% | 0.00% | -100.0% |
| Q3 2018 | $29,103,000 | +55.3% | 2,910,405 | +9.8% | 0.00% | 0.0% |
| Q2 2018 | $18,740,000 | +671.5% | 2,650,612 | +316.9% | 0.00% | – |
| Q1 2018 | $2,429,000 | -55.7% | 635,838 | -5.4% | 0.00% | – |
| Q4 2017 | $5,487,000 | +415.2% | 672,485 | +270.8% | 0.00% | – |
| Q3 2017 | $1,065,000 | +367.1% | 181,359 | +8.9% | 0.00% | – |
| Q2 2017 | $228,000 | -45.2% | 166,487 | -29.1% | 0.00% | – |
| Q1 2017 | $416,000 | – | 234,910 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,192,883 | $15,329,000 | 3.00% |
| Bain Capital Life Sciences Investors, LLC | 1,431,059 | $18,389,000 | 1.71% |
| Avoro Capital Advisors LLC | 3,000,000 | $38,550,000 | 0.55% |
| Palo Alto Investors LP | 31,330 | $403,000 | 0.02% |